Atea Pharmaceuticals (AVIR) Balance Sheet: Assets & Liabilities

Atea Pharmaceuticals (AVIR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Atea Pharmaceuticals reported total assets of $315.22M and total liabilities of $39.78M. Shareholders' equity was $275.43M, down 37.2% from $438.87M a year earlier. Total debt stood at $843.00K against $301.83M in cash and short-term investments, a net cash position of $300.99M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Atea Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Atea Pharmaceuticals, Inc. (AVIR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	95.71	64.70	143.82	188.46	764.38	850.12	21.66	34.49
Short-Term Investments	206.12	390.03	434.28	458.25	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	301.83	454.72	578.11	646.71	764.38	850.12	21.66	34.49
Accounts Receivable	0.00	0.00	5.90	0.00	0.00	5.82	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	9.16	7.63	12.35	14.21	8.03	7.55	0.25	0.21
Total Current Assets	310.99	462.36	590.46	660.92	772.40	863.48	21.91	34.70
Non-Current Assets
Property, Plant & Equipment (Net)	1.09	2.12	3.12	4.09	0.18	0.05	0.04	0.06
Long-Term Investments	0.00	0.00	0.00	0.20	0.31	0.11	0.11	0.11
Other Non-Current Assets	3.14	0.20	1.40	1.69	0.00	0.00	0.02	0.00
Total Non-Current Assets	4.23	2.31	4.51	5.79	0.49	0.16	0.16	0.16
Total Assets	315.22	464.67	594.97	666.71	772.89	863.63	22.07	34.86
Current Liabilities
Accounts Payable	12.95	4.46	4.25	2.55	4.53	0.06	0.55	0.39
Short-Term Debt	0.84	0.80	1.52	0.72	0.20	0.00	0.00	0.00
Accrued Liabilities	26.00	13.35	27.36	15.11	52.15	14.37	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	301.37	0.20	0.20
Other Current Liabilities	26.00	13.35	26.60	15.11	52.15	14.37	1.69	1.37
Total Current Liabilities	39.78	18.60	32.38	18.48	56.88	315.80	2.44	1.76
Non-Current Liabilities
Long-Term Debt	0.00	0.84	1.64	2.40	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	6.36	5.76	5.26	5.93	0.04	0.09	69.26
Total Non-Current Liabilities	0.00	7.20	7.40	7.66	5.93	0.04	0.09	69.26
Total Liabilities	39.78	25.80	39.78	26.14	62.82	315.83	2.53	71.02
Stockholders' Equity
Common Stock	0.08	0.08	0.08	0.08	0.08	0.08	0.01	0.01
Retained Earnings	-522.57	-364.22	-195.84	-59.88	56.03	-65.16	-54.21	-40.18
Accumulated Other Comprehensive Income	0.17	0.23	0.21	-0.68	0.00	-863.63	0.00	-69.11
Additional Paid-in Capital	797.75	802.77	750.74	701.05	653.96	612.88	4.63	4.01
Shares Outstanding	78.13	84.46	83.44	83.29	83.10	-	-	-
Total Stockholders' Equity	275.43	438.87	555.19	640.57	710.08	547.80	19.54	-36.16
Total Liabilities & Equity	315.22	464.67	594.97	666.71	772.89	863.63	22.07	34.86

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Atea Pharmaceuticals Balance Sheet

How much debt does Atea Pharmaceuticals have?

Atea Pharmaceuticals had total debt of $843.00K as of Dec 31, 2025, against $301.83M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $1.64M a year earlier.

What are Atea Pharmaceuticals's total assets?

Atea Pharmaceuticals reported total assets of $315.22M as of Dec 31, 2025, down 32.2% from $464.67M a year earlier. Total liabilities were $39.78M.

What is Atea Pharmaceuticals's shareholders' equity?

Atea Pharmaceuticals's shareholders' equity was $275.43M as of Dec 31, 2025, or about $3.53 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition